Related Articles
Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma
Evaluation of <em>VEGF</em> and <em>VEGFR</em> gene expression as prognostic markers in low and intermediate‑1 risk patients with myelodysplastic syndromes
Co-expression of receptor tyrosine kinases in esophageal adenocarcinoma and squamous cell cancer
Association of plasma VEGF-A, soluble VEGFR-1 and VEGFR-2 levels and clinical response and survival in advanced colorectal cancer patients receiving bevacizumab with modified FOLFOX6
Impact of copy number variant and single nucleotide polymorphism of the programmed death‑ligand 1 gene, programmed death‑ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non‑small cell lung carcinoma